Abstract
In this paper, a recently reported series of NPS antagonists is further expanded and biologically evaluated. The ligand efficiency and ADMET score concepts were then applied to the newly disclosed 5-phenyl-2-[2-(1-piperidinylcarbonyl) phenyl]-2,3-dihydro-1H-pyrrolo[1,2-c]imidazol-1-ones, to limit the SAR exploration. Important pharmacophoric features were identified suggesting potential way forward for the identification of further developable templates.
Keywords: ADMET score, Ligand efficiency, NPS antagonists, Pharmacophore features
Letters in Drug Design & Discovery
Title:Further Insights in 5-phenyl-2-[2-(1-piperidinylcarbonyl) Phenyl]-2,3- dihydro-1H-pyrrolo[1,2-c]imidazol-1-ones, a Recently Disclosed Class of Neuropeptide S Antagonists
Volume: 10 Issue: 5
Author(s): Adelheid Roth, Anna Maria Capelli, Raffaele Longhi, Federica Tonelli, Luca Tarsi, Dino Montanari, Giorgio Bonanomi, Matteo Biagetti, Emilio Merlo-Pich, Gabriele Costantino, Angelo Giacometti, Romano Di Fabio, Angela Worby, Fabrizio Micheli, Elisa Della Turca, Gian Paolo Vallerini, Chiara Pecchini and Marco Mor
Affiliation:
Keywords: ADMET score, Ligand efficiency, NPS antagonists, Pharmacophore features
Abstract: In this paper, a recently reported series of NPS antagonists is further expanded and biologically evaluated. The ligand efficiency and ADMET score concepts were then applied to the newly disclosed 5-phenyl-2-[2-(1-piperidinylcarbonyl) phenyl]-2,3-dihydro-1H-pyrrolo[1,2-c]imidazol-1-ones, to limit the SAR exploration. Important pharmacophoric features were identified suggesting potential way forward for the identification of further developable templates.
Export Options
About this article
Cite this article as:
Roth Adelheid, Maria Capelli Anna, Longhi Raffaele, Tonelli Federica, Tarsi Luca, Montanari Dino, Bonanomi Giorgio, Biagetti Matteo, Merlo-Pich Emilio, Costantino Gabriele, Giacometti Angelo, Di Fabio Romano, Worby Angela, Micheli Fabrizio, Della Turca Elisa, Paolo Vallerini Gian, Pecchini Chiara and Mor Marco, Further Insights in 5-phenyl-2-[2-(1-piperidinylcarbonyl) Phenyl]-2,3- dihydro-1H-pyrrolo[1,2-c]imidazol-1-ones, a Recently Disclosed Class of Neuropeptide S Antagonists, Letters in Drug Design & Discovery 2013; 10 (5) . https://dx.doi.org/10.2174/1570180811310050005
DOI https://dx.doi.org/10.2174/1570180811310050005 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Going up in Smoke? A Review of nAChRs-based Treatment Strategies for Improving Cognition in Schizophrenia
Current Pharmaceutical Design Baculovirus Expression Vectors for Insect and Mammalian Cells
Current Drug Targets Glycine/NMDA Receptor Antagonists as Potential CNS Therapeutic Agents: ACEA-1021 and Related Compounds
Current Topics in Medicinal Chemistry Antiplasmodial, Cytotoxicity and Phytochemical Constituents of Four Maytenus Species Used in Traditional Medicine in Kenya
The Natural Products Journal Multi-Targeted Histone Deacetylase Inhibitors in Cancer Therapy
Current Medicinal Chemistry DNA Repair Proteins as Molecular Therapeutics for Oxidative and Alkylating Lung Injury
Current Gene Therapy National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness- Alzheimers Disease (CATIE-AD): Baseline Characteristics
Current Alzheimer Research Macrocyclic Inhibitors of HCV NS3-4A Protease: Design and Structure Activity Relationship
Current Topics in Medicinal Chemistry A Novel Tetradentate Ruthenium(II) Complex Containing Tris(2- pyridylmethyl)amine (tpa) as an Inhibitor of Beta-Amyloid Fibrillation
Current Alzheimer Research Risk of Animals Spreading COVID-19 to People
Infectious Disorders - Drug Targets Dopamine D5 Receptors: A Challenge to Medicinal Chemists
Mini-Reviews in Medicinal Chemistry Syntheses and In-Vitro Evaluation of Novel Adamantane Based γ-Secretase Inhibitors
Current Medicinal Chemistry The Design of Competitive, Small-molecule Inhibitors of Coagulation Factor Xa
Current Topics in Medicinal Chemistry Potential Leads from Liquorice Against SARS-CoV-2 Main Protease using Molecular Docking Simulation Studies
Combinatorial Chemistry & High Throughput Screening Preface
Drug Delivery Letters Integrity Profiling of High Throughput Screening Hits Using LC-MS and Related Techniques
Combinatorial Chemistry & High Throughput Screening Formulation Optimization and Evaluation of Nanocochleate Gel of Famciclovir for the Treatment of Herpes Zoster
Recent Patents on Nanotechnology Agonists and Antagonists of Protease Activated Receptors (PARs)
Current Medicinal Chemistry Tryptanthrin Analogues as Inhibitors of Enoyl-acyl Carrier Protein Reductase: Activity against Mycobacterium tuberculosis, Toxicity, Modeling of Enzyme Binding
Current Topics in Medicinal Chemistry Thiol Proteases: Inhibitors and Potential Therapeutic Targets
Current Medicinal Chemistry